Anzeige
Mehr »
Freitag, 04.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 859034 | ISIN: US1266501006 | Ticker-Symbol: CVS
Tradegate
04.09.26 | 12:43
83,38 Euro
-0,24 % -0,20
1-Jahres-Chart
CVS HEALTH CORPORATION Chart 1 Jahr
5-Tage-Chart
CVS HEALTH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
83,0483,4015:31
83,0483,4015:31
ACCESS Newswire
188 Leser
Artikel bewerten:
(1)

CVS Health: Living With Primary Immunodeficiency: How Specialty Care Supports Nick's Journey

  • Diagnosed with primary immunodeficiency (PI) as an infant, Nick Stacken has spent decades pursuing his passions, including competing in Special Olympics.

  • Immunoglobulin (Ig) Therapy is often key to PI care, but ongoing support from pharmacists, nurses and caregivers can help patients build confidence and support their long-term health and personal goals.

  • CVS Specialty/Coram supports patients receiving Ig Therapy through specialized pharmacy services, in-home nursing support, patient education and personalized care.

Originally published on CVS Health Company Newsroom

NORTHAMPTON, MA / ACCESS Newswire / September 4, 2026 / Nick Stacken loves sports. In fact, he's been a Special Olympian in his state for two decades. Now his sights are set on participating at the national level.

Learn more about Nick's story here.

For his mother and caregiver, Wendy Stacken, that future once seemed impossible.

"Nick was born with multiple health issues," Wendy recalls. "He kept getting sick. We'd take him to the hospital and we'd be back again hours later. It was terrifying."

At 13 months old, he was diagnosed with primary immunodeficiency (PI), a group of rare disorders that impair the immune system's ability to fight infection.

  • According to the Centers for Disease Control, people living with PI often face an increased risk of autoimmune diseases, certain cancers and other serious health complications.

The right therapy, the right support

Nick's access to appropriate therapies and the support of trusting relationships, including with his in-home CVS Specialty/Coram nurses, have simplified his health care and supported his quality of life.

Since his diagnosis, a key part of Nick's care has been Immunoglobulin (Ig) Therapy, administered by his CVS Specialty/Coram nurses, which provides antibodies that help protect against infections.

  • The therapy is important: Ig therapy has been shown to reduce hospitalizations by more than 50%, according to the Immune Deficiency Foundation.

Yet for the Stacken family, Ig Therapy has only been one part of the equation. Wendy notes that the CVS Specialty/Coram nurses go beyond administering therapy. They help the family navigate treatment, monitor changes and stay connected with the broader care team.

"Jackee, is like family," says Wendy. "She's been there to help us understand the therapy, answer questions and spot when something doesn't seem right."

Wendy also points to the reassurance of having 24/7 access to CVS Specialty pharmacist support when questions arise. "There have been many times I've had to call at three o'clock in the morning," she says. "And they answer."

Supporting patients beyond the prescription

"For patients like Nick, getting on the right therapy can be life-changing - and in many cases, lifesaving. But it's often the trusted relationships around that therapy that help patients thrive," says Lucille Accetta, Chief Pharmacy Officer and Head of CVS Specialty, who notes stories like Nick's illustrate the broader goal of specialty care. "When patients, caregivers and care teams build trusted relationships over time they gain more than access to treatment. They gain the confidence, continuity and peace of mind that helps make everyday milestones possible."

Today, Nick is 31 and thriving. He continues to pursue new goals and opportunities, including his aspiration to compete in the Special Olympics at the national level - a possibility that once seemed out of reach for his family.

How CVS Specialty supports patients with Ig Therapy

For people living with primary immunodeficiency and other conditions treated with Immunoglobulin (Ig) Therapy, managing care can be complex.

CVS Specialty's IG Center of Excellence-one of more than 30 condition-specific Centers of Excellence-brings together pharmacists, nurses and CareTeams with specialized training and experience supporting patients on Ig therapy.

CVS Specialty/Coram support includes:

  • Personalized education and support for patients and caregivers, helping them understand treatment, administration options and what to expect throughout therapy.

  • End-to-end coordination of Ig Therapy, from onboarding and benefits verification to medication delivery, nursing support and ongoing patient education.

  • Nursing support and training, including in-home infusion services and patient training for those who may be able to self-administer therapy at home when appropriate.

  • 24/7 access to specialty pharmacists who can answer questions and provide clinical support when patients and caregivers need it.

  • Digital and high-touch support options tailored to individual preferences, including refill management, delivery tracking and proactive outreach

At the heart of the model is a simple goal: helping patients and caregivers spend less time navigating the complexities of care and more time focusing on what matters most to them.

Find more stories and multimedia from CVS Health at 3blmedia.com.

Contact Info:
Spokesperson: CVS Health
Website: https://www.3blmedia.com/profiles/cvs-health
Email: info@3blmedia.com

SOURCE: CVS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/living-with-primary-immunodeficiency-how-specialty-care-supports-nick-1216914

© 2026 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.